On Thursday, Shares of Manulife Financial Corporation (USA) (NYSE:MFC), remained flat at $17.81.
Manulife Financial Corporation, declared the planned installation of about 830 automated banking machines (ABMs) in select Mac’s, Couche-Tard and Circle K locations across Canada to assist customers better meet their day-to-day banking needs.
Manulife Bank will add ABMs in British Columbia, the Northwest Territories, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Newfoundland and New Brunswick. The machines will be managed by Stanley Security, a global provider of security products and services with a specialty in financial solutions, which is delivering comprehensive monitoring and administration of the ABM networks. The ABM deployment is predictable to be complete by the end of September.
Manulife Financial Corporation, together with its auxiliaries, provides financial protection and wealth administration products and services to individual, corporate, and business customers primarily in Asia, Canada, and the United States.
Shares of 3M Co (NYSE:MMM), inclined 0.68% to $153.75, during its last trading session.
A national leader in healthcare delivery innovation and population health, the State of Minnesota will use data analytics from 3M to assist improve the quality and value of the care offered to Minnesota citizens served by public health care. The Minnesota Department of Human Services has selected 3M Health Information Systems as its analytics contractor to support Minnesota’s Integrated Health Partnership (IHP) demonstration, a groundbreaking initiative that tests new approaches to health care delivery and payment.
3M Health Information Systems will provide data administration, analysis, and data access and reporting resources to assist Minnesota IHP organizations analyze cost of care, utilization of services, and risk data so they can identify opportunities for cost and care transformation. The 16 healthcare organizations participating in IHP serve over 204,000 Minnesotans enrolled in Medical Assistance.
3M Company operates as a diversified technology company worldwide. Its Industrial segment offers tapes; coated, non-woven, and bonded abrasives; adhesives; ceramics; sealants; specialty materials; filtration products; closure systems for personal hygiene products; acoustic systems products; automotive components; abrasion-resistant films; structural adhesives; and paint finishing and detailing products.
At the end of Thursday’s trade, Shares of Dynavax Technologies Corporation (NASDAQ:DVAX), surged 8.27% to $26.44.
Dynavax Technologies Corporation, declared that the independent Data and Safety Monitoring Board (DSMB) charged with periodically reviewing safety data from HBV-23, the ongoing Phase 3 clinical study of HEPLISAV-B, Dynavax’s investigational adult hepatitis B vaccine, has accomplished its third pre-specified review and has recommended that the study continue unchanged.
The third DSMB review comprised of safety data for all enrolled subjects collected through the data cut-off in June. As of the cut-off, all ongoing subjects who had received the second immunization (which was the last active dose for HEPLISAV-B subjects) had reached at least 8 months of the requisite one year follow-up after the second immunization. The DSMB reviewed unblinded tables and listings presenting key safety data. Based on this review, the DSMB recommended ongoing HBV-23 with no change to the study.
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. It development programs focus on the areas of vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases.
Finally, Mindray Medical International Ltd (ADR) (NYSE:MR), ended its last trade with 0.86% gain, and closed at $25.73.
Mindray Medical International, declared a definitive agreement to acquire the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. for about US$72.6 million.
Dragonbio is a domestic medical orthopedic-product provider that specializes in trauma, spine, joint and other surgical products. Preceding to today’s declaration, Mindray already has a controlling stake of Dragonbio, which was attained in 2012. The transaction will be funded through Mindray’s existing cash reserves and is predictable to close in July. Mindray anticipates the deal to have non-material impact on its 2015 financial results.
Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
